Evaluating the Effectiveness of Adding Rituximab to Standard Treatment for Thrombotic Thrombocytopenic Purpura (TTP)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Barbara Konkle, MD
University of Pennsylvania
Principal Investigator - Christopher Hillyer, MD
Emory University
Principal Investigator - Cindy Leissinger, MD
Tulane University
Principal Investigator - Darrell Triulzi, MD
University of Pittsburgh Presbyterian and Shadyside/Children's Hospital Pittsburgh
Principal Investigator - David Kuter, MD
Massachusetts General Hospital
Principal Investigator - Eliot Williams, MD, PhD
University of Wisconsin, Madison
Principal Investigator - Ellis Neufeld, MD
Boston Children's Hospital
Principal Investigator - James Bussel, MD
Weill Medical Colllege, Cornell University
Principal Investigator - James George, MD
University of Oklahoma
Principal Investigator - Jan McFarland, MD
Froedtert Hospital
Principal Investigator - John Hess, MD
University of Maryland
Principal Investigator - Joseph Kiss, MD
University of Pittsburgh
Study Chair - Keith McCrae, MD
University Hospitals Cleveland Medical Center
Principal Investigator - Mark Brecher, MD
University of North Carolina, Chapel Hill
Principal Investigator - Paul Ness, MD
Johns Hopkins University
Principal Investigator - Ronald Strauss, MD
University of Iowa
Principal Investigator - Sherrill Slichter, MD
University of Washington Medical Center/Fred Hutchinson Cancer Research Center (FHCRC)
Principal Investigator - Susan F. Assmann, PhD
New England Research Institutes, Inc.
Principal Investigator - Thomas Ortel, MD
Duke University
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
23 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Alabama, Birmingham
Birmingham, Alabama, United States
- Emory University
Atlanta, Georgia, United States
- University of Iowa
Iowa City, Iowa, United States
- Tulane University Health Sciences Center
New Orleans, Louisiana, United States
- Johns Hopkins Hospital
Baltimore, Maryland, United States
- University of Maryland Medical Center
Baltimore, Maryland, United States
- Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States
- Brigham and Women'S Hospital
Boston, Massachusetts, United States
- Children'S Hospital Boston
Boston, Massachusetts, United States
- Massachusetts General Hospital
Boston, Massachusetts, United States
- New York-Presbyterian Hospital/weill Cornell Medical Center
New York, New York, United States
- University of North Carolina Hospitals
Chapel Hill, North Carolina, United States
- Duke University Medical Center
Durham, North Carolina, United States
- University Hospital Cleveland
Cleveland, Ohio, United States
- Integris Baptist Medical Center
Oklahoma City, Oklahoma, United States
- University of Oklahoma Health Sciences Center
Oklahoma City, Oklahoma, United States
- University of Pennsylvania
Philadelphia, Pennsylvania, United States
- Children'S Hospital of Pittsburgh
Pittsburgh, Pennsylvania, United States
- University of Pittsburgh Presbyterian and Shadyside Hospital
Pittsburgh, Pennsylvania, United States
- Puget Sound Blood Center
Seattle, Washington, United States
- Gunderson Clinic, Ltd
La Crosse, Wisconsin, United States
- University of Wisconsin at Madison
Madison, Wisconsin, United States
- Froedtert Memorial Lutheran Hospital
Milwaukee, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Apr 2009
- Primary completion
- 28 Feb 2010
- Completion
- 28 Feb 2010
- Last update posted
- 22 Jul 2013
- Registered enrollment
- 3
- Registry id
- NCT00799773
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.